Back to SYRE
DRIEHAUS CAPITAL MANAGEMENT LLC → SYRE
DRIEHAUS CAPITAL MANAGEMENT LLC SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$245.8M
Q3 2026
Peak value
$248.5M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $94.4M |
| Q1 2026 | $140.8M |
| Q2 2026 | $248.5M |
| Q3 2026 | $245.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $245.8M | 2.76M | — | — |
| Q2 2026 | $248.5M | 2.80M | — | — |
| Q1 2026 | $140.8M | 2.79M | — | — |
| Q4 2025 | $94.4M | 2.88M | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$383.5M
$377.5M
$348.1M